Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 13, 2026
Bending Spoons (BSP): Path Toward $60 After Recent Highs and Pullback

Bending Spoons (BSP): Path Toward $60 After Recent Highs and Pullback

Key Takeaways

  • Selected price target: $60 per share, a psychological and technical level just above the August record high of $58.94.
  • Strongest bullish factors: a proven acquisition-and-transformation model, Mizuho's raised $72.28 price target, and rapid revenue growth.
  • Biggest risks: premium valuation, substantial debt, and a consensus analyst price target near $40.36 that sits below the latest market price.
  • Key levels: support in the $47–$48 zone, followed by $40–$42; resistance near $53, $58.94, and then $60.
  • Key takeaway: $60 is plausible over a longer horizon, but it requires strong execution, margin progress, and sustained market confidence rather than momentum alone.

Why the $60 Level Stands Out

The $60 stock price target has not been reached yet, but it is close enough to be a realistic extension of the recent rally. Bending Spoons touched $58.94 on Aug. 11, leaving $60 as the next obvious round-number objective. With the latest close at $48.98, reaching $60 would require a gain of roughly 22%. That is not a trivial move, but it is far from speculative for a stock that nearly doubled from its $29 IPO price in a matter of weeks.

A Serial Acquirer With Momentum

The Bending Spoons story is built on mergers and acquisitions (M&A). The company buys mature digital businesses, restructures them, improves monetization, and reinvests cash flow into new deals. Its portfolio includes AOL, Brightcove, Eventbrite, Evernote, Vimeo, WeTransfer, and Remini, among others. Revenue over the trailing twelve months reached about $1.65 billion, up 94.7% year over year. In early August, the company announced a $1.285 billion enterprise-value agreement for Airtable, a deal that reinforced the view that its acquisition playbook can scale.

On Aug. 11, Mizuho raised its price target to $72.28 from $45, maintaining an Outperform rating. The firm cited peer multiple expansion and continued M&A opportunities, with a bull case of $95 and a bear case of $29. That high-profile target alone puts $60 within the range of credible analyst scenarios if execution matches the bullish outlook. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Valuation and Balance Sheet Risks

The biggest obstacle to a sustainable move toward $60 is valuation. The stock trades at a very high trailing price-to-earnings (P/E) ratio, and even the forward P/E remains elevated. According to S&P Global data, 11 analysts have an average price target of about $40.36, below the latest market price. Bank of America Securities downgraded the stock on Aug. 12 with a $39 target, while other early targets cluster in the $35–$45 range. That gap between the share price and the consensus analyst price target shows how much optimism is already embedded.

Leverage adds another layer of risk. The company carries roughly $4.4 billion in debt, and its current ratio is below 1.0, meaning short-term obligations exceed liquid assets. The model can produce powerful growth, but it depends on continued access to financing and successful integration of acquisitions.

Technical Levels That Matter

On the chart, $60 is meaningful because it is the next major round-number level after the 52-week high of $58.94. To get there, the stock would first need to reclaim the $53 area, near the Aug. 12 previous close, and then clear the $58.94 record high. On the downside, the $47–$48 zone is the first major support, followed by the $40–$42 area, where several analyst targets cluster. A decisive break below $45 would weaken the near-term technical case and shift attention back toward lower levels. From what I see, these levels align with patterns I’ve observed in similar growth names.

What Would Likely Need to Happen

A move toward $60 would probably require three conditions. First, Bending Spoons would need to deliver quarterly results and guidance that support the M&A-driven growth narrative. Second, the Airtable transaction would need to close and begin showing margin improvement without stretching the balance sheet further. Third, the broader market would need to remain receptive to high-growth, high-valuation software stocks. If those conditions align, the psychological target becomes achievable; if any one fails, the stock may remain rangebound or retest lower support.

Final Assessment

A move to $60 is realistic but not guaranteed. The bullish case is supported by rapid revenue growth, a differentiated acquisition strategy, and Mizuho's above-consensus price target. The bearish case is just as clear: the stock already trades above the average analyst target, carries substantial debt, and remains exposed to execution risk around new acquisitions. Investors should monitor quarterly results, Airtable integration progress, and whether the stock can hold the $47–$48 support zone while attempting to reclaim $53 and eventually the $58.94 high.

AI Daily Buy/Sell Signals

One tool I find particularly helpful for following volatile newly public growth stories like Bending Spoons is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This helps filter short-term price swings and focus on actionable changes in a name that has moved sharply since its IPO.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BSP

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.31B. The market cap for tickers in the group ranges from 291 to 240.81B. SAP holds the highest valuation in this group at 240.81B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 8%. YXT experienced the highest price growth at 62%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.